How Treatment Monitoring Is Influencing Treatment Decisions in Glioblastomas
Explore this paper's citation graph
Summary
Improved radiographic interpretation criteria, such as the Response Assessment in Neuro-Oncology (RANO) criteria, incorporate non-enhancing disease but still fall short of definitely distinguishing tumor progression, pseudoresponse, and pseudoprogression.
- Type
- article
- Published
- 2015-03-10
- Cited by
- 18
- References
- 99
- OpenAlex
- https://openalex.org/W25749847
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:13284710
Keywords
Humanities, Political science, Art
References
- Magnetic resonance imaging appearance and changes on intracavitary Gliadel wafer placement: A pilot study.
- NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
- CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
- Assessment of early therapy response with 18F-FLT PET in glioblastoma multiforme.
- Radiation therapy of glioblastoma.
- Epidemiology of gliomas.
- Glioblastoma in the elderly.
- Current medical treatment of glioblastoma.
- Scientific Statement From the American Heart Association State of the Science: Promoting Self-Care in Persons With Heart Failure: A
- Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
- The Neurologic Assessment in Neuro-Oncology (NANO) Scale: A Tool to Assess Neurologic Function for Integration in the Radiologic Assessment in Neuro-Oncology (RANO) Criteria (S22.005)
- Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
- Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
- Tumor angiogenesis: therapeutic implications.
- The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
- Molecular mechanisms and clinical applications of angiogenesis
- Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases.
- The first 3 months after BCNU wafers implantation in high-grade glioma patients: clinical and radiological considerations on a clinical series
- Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
- Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions.
Cited by
- Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma
- Monitoring the Bystander Killing Effect of Human Multipotent Stem Cells for Treatment of Malignant Brain Tumors
- Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis
- Behavioral management of headache in children and adolescents
- Liquid biopsy for brain tumors
- Interval brain imaging for adults with cerebral glioma.
- The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives
- Identification of Circulating MicroRNAs as Biomarkers in Glioblastoma
- “Liquid biopsy” for brain tumors: state of problem
- Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
- The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy.
- MiR-186 promotes the apoptosis of glioma U87 cells by down-regulating the expression of Smad6.
- Recent Advances in Liquid Biopsy of Brain Cancers
- Investigation of glial fibrillary acidic protein (GFAP) in body fluids as a potential biomarker for glioma: a systematic review and meta-analysis
- MicroRNA-3200-3p targeting CAMK2A modulates the proliferation and metastasis of glioma in vitro
- Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment
- A neural tract-inspired conduit for facile, on-demand biopsy of glioblastoma
- Decoding Glioblastoma Through Liquid Biopsy: Molecular Insights and Clinical Prospects
Related papers
No related papers recorded.